BG Medicine this week announced the appointment of Brian Posner to its board of directors.
Posner is president of the consulting and advisory services firm Point Rider Group. Previously he was CEO and co-chief investment officer of ClearBridge Advisors. He also serves as a director at Biogen Idec, Arch Capital Group, and the AQR Funds.
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
